Intellectual Property India Publishes Patent Application for 'Stable And Potent Anti-Angiogenic Scfv Fragments And Uses As Vegf Antagonist Thereof' Filed by Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi

MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202517023516 A) filed by Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi, Istanbul, on March 17, for 'stable and potent anti-angiogenic scfv fragments and uses as vegf antagonist thereof.'

Inventor(s) include Can, Efe; Kalyoncu Uzunlar, Sibel; Gullu, Seyda; Ozer Cokgezme, Ceren; Cakan Akdogan, Gulcin; Inan, Mehmet; and Onal, Ebru.

The application for the patent was published on May 2, under issue no. 18/2025.

According to the abstract released by the Intellectual Property India: "The present invention discloses and claims a functional antibody fragment as an anti-angiogenic scFv fragment and also as an inhibitor of VEGF:VEGFR interaction by binding to...